1. An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy. (30th June 2020) Authors: Yossef, Sayed; Clark, Frances; Bubeck, Sarah S.; Abernethy, John; Bayne, Thomas; Krishnan, Kiran; Young, Aicacia Other Names: Bastos Jairo Kenupp Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗